Sanofi lifts earnings outlook on new drug launches, Dupixent sales
By Ludwig Burger (Reuters) -French drugmaker Sanofi on Friday increased
dupixent
Sanofi and Regeneron present more positive data for Dupixent product
PARIS (Reuters) – Healthcare companies Sanofi and partner Regeneron presented
Sanofi’s Dupixent wins U.S. approval for bigger use
(Reuters) -Sanofi won expanded U.S. approval for its best-selling Dupixent